O Brien Wealth Partners LLC Lowers Stock Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

O Brien Wealth Partners LLC lowered its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST) by 24.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 537,901 shares of the company’s stock after selling 178,281 shares during the quarter. LifeStance Health Group makes up 0.8% of O Brien Wealth Partners LLC’s portfolio, making the stock its 17th biggest position. O Brien Wealth Partners LLC owned 0.14% of LifeStance Health Group worth $3,319,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Charles Schwab Investment Management Inc. raised its holdings in shares of LifeStance Health Group by 0.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 744,617 shares of the company’s stock valued at $5,830,000 after purchasing an additional 5,112 shares in the last quarter. Brown Advisory Inc. raised its stake in shares of LifeStance Health Group by 25.9% during the 4th quarter. Brown Advisory Inc. now owns 5,158,980 shares of the company’s stock worth $40,395,000 after acquiring an additional 1,062,887 shares in the last quarter. Principal Financial Group Inc. raised its stake in shares of LifeStance Health Group by 2.8% during the 4th quarter. Principal Financial Group Inc. now owns 4,006,344 shares of the company’s stock worth $31,370,000 after acquiring an additional 110,457 shares in the last quarter. Assetmark Inc. raised its stake in shares of LifeStance Health Group by 21.6% during the 4th quarter. Assetmark Inc. now owns 11,895 shares of the company’s stock worth $93,000 after acquiring an additional 2,114 shares in the last quarter. Finally, SG Americas Securities LLC raised its stake in shares of LifeStance Health Group by 37.6% during the 4th quarter. SG Americas Securities LLC now owns 41,325 shares of the company’s stock worth $324,000 after acquiring an additional 11,295 shares in the last quarter. Institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Trading Up 1.0 %

Shares of NASDAQ LFST traded up $0.05 during mid-day trading on Monday, reaching $4.96. The company’s stock had a trading volume of 1,119,686 shares, compared to its average volume of 1,469,465. The stock has a 50-day moving average of $6.02 and a two-hundred day moving average of $6.48. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.18 and a quick ratio of 1.18. LifeStance Health Group, Inc. has a 1-year low of $4.64 and a 1-year high of $9.52.

LifeStance Health Group (NASDAQ:LFST) last issued its earnings results on Thursday, May 9th. The company reported ($0.06) EPS for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.03. The business had revenue of $300.44 million during the quarter, compared to analysts’ expectations of $299.02 million. LifeStance Health Group had a negative net margin of 15.69% and a negative return on equity of 11.92%. The company’s quarterly revenue was up 18.9% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.09) earnings per share. On average, research analysts forecast that LifeStance Health Group, Inc. will post -0.26 EPS for the current fiscal year.

Insider Buying and Selling

In related news, major shareholder Summit Partners Growth Equity sold 3,802,345 shares of the firm’s stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $5.89, for a total transaction of $22,395,812.05. Following the completion of the sale, the insider now directly owns 41,932,358 shares in the company, valued at $246,981,588.62. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other LifeStance Health Group news, major shareholder Summit Partners Growth Equity sold 3,802,345 shares of the stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $5.89, for a total transaction of $22,395,812.05. Following the completion of the transaction, the insider now owns 41,932,358 shares of the company’s stock, valued at $246,981,588.62. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Paula Cipollone sold 48,278 shares of the stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $7.22, for a total transaction of $348,567.16. Following the transaction, the insider now directly owns 239,915 shares of the company’s stock, valued at approximately $1,732,186.30. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 4,087,716 shares of company stock worth $24,010,444. Insiders own 6.60% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently commented on LFST shares. Jefferies Financial Group boosted their price objective on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock a “buy” rating in a research note on Wednesday, March 6th. Morgan Stanley restated an “overweight” rating and set a $10.00 price target on shares of LifeStance Health Group in a research note on Monday, April 22nd. Finally, The Goldman Sachs Group upped their price target on shares of LifeStance Health Group from $8.00 to $9.00 and gave the company a “neutral” rating in a research note on Monday, March 4th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, LifeStance Health Group has a consensus rating of “Hold” and an average price target of $8.80.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.